Learn with us

December 8, 2023
Peter Montoya

Ketamine for Treatment-Resistant Depression: Assessing Safety and Application

Ketamine is seeing a resurgence in its medical application, particularly in treating treatment-resistant depression (TRD).

December 8, 2023

How Ketamine Drug Helps with Depression

The groundbreaking approval of a ketamine-based nasal spray by the FDA on March 5, 2019, marked a major advancement in the treatment of major depression.

December 8, 2023
Peter Montoya

Ketamine Found Effective in Treating Severe Depression

Massachusetts General Brigham (MGB) researchers made a significant discovery in the treatment of severe depression.

October 5, 2023
Peter Montoya

Dispelling Myths: Is Ketamine an Opioid?

A common question that arises is, "Is ketamine an opioid?" The straightforward answer is no, ketamine is not an opioid.

October 5, 2023
Peter Montoya

Understanding Ketamine Side Effects

Side effects may include: feelings of dissociation or being detached from the body, dizziness or lightheadedness, nausea and vomiting, elevated blood pressure, blurred vision & slurred speech.

October 5, 2023
Peter Montoya

What are Ketamine Uses: From Anesthesia to Mental Health

Ketamine is a versatile medication with several uses in modern medicine, primarily known for its anesthetic properties but increasingly recognized for its potential in treating certain mental health conditions.

October 5, 2023
Peter Montoya

Exploring Ketamine as a Treatment for Depression

Ketamine has emerged as a potential game-changer in the treatment of depression, particularly for cases that have not responded to traditional therapies.

Request a consultation with one of our professional clinicians or sign up for our email newsletter where we share the latest news, education, events, and research in the psychedelic space.
Solutions
Psychedelics
Inner Exploration
Depression
Anxiety
Resources
Why
Learn
Careers
Press
About
Manifesto
Terms & Conditions
Privacy Policy
Copyright © 2023 Deeply Inc